NCT07916688
Lactic Acid Bacteria in Functional Diarrheal Disorders
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Irritable Bowel Syndrome Quality of Life (IBS-QOL) Total Score at 3 Months
Timeframe: Three months after enrollment
Secondary (5)
Irritable Bowel Syndrome Quality of Life (IBS-QOL) Total Score at 6 Months
Mean Daily Stool Frequency at 3 Months
Mean Daily Stool Frequency at 6 Months
Mean Bristol Stool Form Scale Score at 3 Months
Mean Bristol Stool Form Scale Score at 6 Months
Arms and interventions
Experimental First ArmExperimental
Participants randomized to this arm will receive LL1500, a probiotic supplement containing Lactobacillus rhamnosus and Lactobacillus plantarum, once daily for 3 months, followed by crossover to matching placebo for an additional 3 months under double-blind conditions.
Placebo First ArmPlacebo comparator
Participants randomized to this arm will receive matching placebo once daily for 3 months, followed by crossover to LL1500, a probiotic supplement containing Lactobacillus rhamnosus and Lactobacillus plantarum, for an additional 3 months under double-blind conditions.
Dietary supplements: LL1500
Other: Placebo Capsule
Sites
1 site in 1 country
- University of SzegedSzeged, Hungary